Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fort Worth, TX
NPI
1326402504
Since 2016
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6844 Harris Pkwy Ste 300
Fort Worth, TX, 76132
Phone (817) 263-0007
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
1,269 services
Medicare patients, 2024
458
Average age 74
Drug cost, 2024
$903K
2,392 prescriptions
Company payments, 2025
$399
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farheen Saeed was code 99214 (office e&m - established), 449 times for 279 patients. In total Farheen Saeed billed 1,269 services in 30 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 449 | 279 | $67.05 | $30K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 347 | 253 | $12.04 | $4,177 |
| 99204 Office E&M - New | Facility | 150 | 150 | $90.21 | $14K |
| 95251 Test - Miscellaneous | Facility | 60 | 32 | $26.02 | $1,561 |
| 99214 Office E&M - Established | Office | 56 | 36 | $68.21 | $3,820 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 46 | 33 | $11.31 | $520 |
| 36415 Venipuncture Blood Collection | Office | 38 | 32 | $8.65 | $329 |
| 99213 Office E&M - Established | Facility | 28 | 27 | $42.74 | $1,197 |
| 99204 Office E&M - New | Office | 12 | 12 | $70.27 | $843 |
By year: 2022 $47K for 700 services; 2023 $56K for 909 services; 2024 $60K for 1,269 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 38 | 32 | $8.65 | $329 |
Medicare prescription drug claims, 2024
In 2024, the drug Farheen Saeed prescribed most often to Medicare patients was Ozempic (Semaglutide), with 244 prescriptions and refills. In total Farheen Saeed wrote 2,392 Medicare prescriptions that cost $903K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 244 | 313 | 46 | $262K |
| Levothyroxine Sodium Generic | 193 | 398 | 46 | $1,469 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 158 | 323 | 48 | $19K |
| Alendronate Sodium Generic | 105 | 280 | 37 | $827 |
| Glimepiride Generic | 95 | 234 | 34 | $1,928 |
| Humalog Kwikpen U-100 Insulin Lispro | 90 | 145 | 23 | $21K |
| Jardiance Empagliflozin | 86 | 146 | 20 | $75K |
| Methimazole Generic | 84 | 148 | 16 | $649 |
| Januvia Sitagliptin Phosphate | 76 | 118 | 19 | $64K |
| Metformin Hcl Generic | 75 | 209 | 27 | $544 |
| Mounjaro Tirzepatide | 72 | 77 | 15 | $74K |
| Testosterone Cypionate Generic | 71 | 146 | 18 | $1,893 |
| Tresiba Flextouch U-100 Insulin Degludec | 61 | 99 | 15 | $41K |
| Trulicity Dulaglutide | 59 | 72 | 14 | $68K |
| Metformin Hcl Er Metformin Hcl | 59 | 158 | 17 | $848 |
Brand drugs: 1,404 claims; generic drugs: 876 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farheen Saeed $399 ($399 in general payments such as food, travel and fees) from 7 companies. The largest payer was Amgen Inc. with $165.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.